EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C20H30O2 |
| Net Charge | 0 |
| Average Mass | 302.458 |
| Monoisotopic Mass | 302.22458 |
| SMILES | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O |
| InChI | InChI=1S/C20H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-19H2,1H3,(H,21,22)/b4-3-,7-6-,10-9-,13-12-,16-15- |
| InChIKey | JAZBEHYOTPTENJ-JLNKQSITSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Daphnia galeata (ncbitaxon:27404) | - | Article (Is the fatty acid composition of Daphnia galeata determined by the fatty acid composition of the ingested diet?Weers P.M.M., Siewertsen K., and Gulati R.D.Freshwater Biology (1997), 38, 731-738) | |
| Mortierella alpina (ncbitaxon:64518) | - | PubMed (9668087) | |
| Mus musculus (ncbitaxon:10090) | - | MetaboLights (MTBLS143) |
| Roles Classification |
|---|
| Chemical Roles: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Roles: | fungal metabolite Any eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds. micronutrient Any nutrient required in small quantities by organisms throughout their life in order to orchestrate a range of physiological functions. mouse metabolite Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus). Daphnia galeata metabolite A Daphnia metabolite produced by the species Daphnia galeata. marine metabolite Any metabolite produced during a metabolic reaction in marine macro- and microorganisms. plant metabolite Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. human metabolite Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens). bacterial metabolite Any prokaryotic metabolite produced during a metabolic reaction in bacteria. |
| Applications: | nutraceutical A product in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. anticholesteremic drug A substance used to lower plasma cholesterol levels. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) has role Daphnia galeata metabolite (CHEBI:83038) |
| all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) has role anticholesteremic drug (CHEBI:35821) |
| all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) has role antidepressant (CHEBI:35469) |
| all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) has role antineoplastic agent (CHEBI:35610) |
| all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) has role fungal metabolite (CHEBI:76946) |
| all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) has role micronutrient (CHEBI:27027) |
| all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) has role mouse metabolite (CHEBI:75771) |
| all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) has role nutraceutical (CHEBI:50733) |
| all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) is a icosapentaenoic acid (CHEBI:36006) |
| all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) is a ω−3 fatty acid (CHEBI:25681) |
| all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) is conjugate acid of all-cis-5,8,11,14,17-icosapentaenoate (CHEBI:58562) |
| Incoming Relation(s) |
| (5Z,11Z,14Z,17Z)-8,9-epoxyicosatetraenoic acid (CHEBI:137193) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| (5Z,8Z,11Z,14Z,16E,18R)-18-hydroperoxyicosapentaenoic acid (CHEBI:138565) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| (5Z,8Z,11Z,14Z,17Z)-icosapentaenoyl-containing glycerolipid (CHEBI:90083) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| (5Z,8Z,11Z,14Z,17Z)-icosapentaenoylethanolamine (CHEBI:71467) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| (5Z,8Z,11Z,17Z)-14,15-epoxyicosatetraenoic acid (CHEBI:137269) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| (5Z,8Z,14Z,17Z)-11,12-epoxyicosatetraenoic acid (CHEBI:137267) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| (5Z,9E,11Z,14Z,17Z)-8-hydroperoxyicosapentaenoic acid (CHEBI:136656) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| (6E,8Z,11Z,14Z,17Z)-5-oxoicosapentaenoic acid (CHEBI:140244) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| 1-[(11Z)-octadecenoyl]-2-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-sn-glycero-3-phosphocholine (CHEBI:86186) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| 1-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-2-[(9Z)-octadecenoyl]-sn-glycero-3-phosphocholine (CHEBI:86183) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| 1-[(9Z)-octadecenoyl]-2-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-sn-glycero-3-phosphocholine (CHEBI:86187) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| 1-hexadecanoyl-2-[(5Z,8Z,11Z,14Z,17Z)-icosapentaenoyl]-sn-glycero-3-phosphocholine (CHEBI:86137) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| 1-hexadecyl-2-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-sn-glycero-3-phosphocholine (CHEBI:86437) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| 1-icosanoyl-2-[(5Z,8Z,11ZZ,14Z,17Z)-eicosapentaenoyl]-sn-glycerol (CHEBI:87225) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| 1-octadecanoyl-2-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-sn-glycero-3-phosphocholine (CHEBI:86181) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| 11-HEPE (CHEBI:131889) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| 12-HPEPE (CHEBI:78909) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| 17(18)-EpETE (CHEBI:72853) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| 19-HEPE (CHEBI:76959) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| 2-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-sn-glycerol (CHEBI:86398) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| 20-HEPE (CHEBI:76962) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| 5,20-diHEPE (CHEBI:130073) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| cholesteryl (5Z,8Z,11Z,14Z,17Z-eicosapentaenoate) (CHEBI:84969) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate (CHEBI:84883) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| timnodonoyl bioconjugate (CHEBI:76189) has functional parent all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| all-cis-5,8,11,14,17-icosapentaenoate (CHEBI:58562) is conjugate base of all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| (5Z,8Z,11Z,14Z,17Z)-icosapentaenoyl group (CHEBI:85943) is substituent group from all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) |
| IUPAC Name |
|---|
| (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid |
| INNs | Source |
|---|---|
| icosapent | ChemIDplus |
| icosapento | ChemIDplus |
| icosapentum | ChemIDplus |
| Synonyms | Source |
|---|---|
| 5,8,11,14,17-EICOSAPENTAENOIC ACID | PDBeChem |
| 5,8,11,14,17-Icosapentaenoic acid | KEGG COMPOUND |
| (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaenoic acid | ChemIDplus |
| (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate | KEGG COMPOUND |
| (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid | KEGG COMPOUND |
| (5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid | KEGG COMPOUND |
| Manual Xrefs | Databases |
|---|---|
| 3174 | DrugCentral |
| C00000408 | KNApSAcK |
| C00001215 | KNApSAcK |
| C06428 | KEGG COMPOUND |
| D08061 | KEGG DRUG |
| DB00159 | DrugBank |
| EICOSAPENTAENOATE | MetaCyc |
| EPA | PDBeChem |
| HMDB0001999 | HMDB |
| LMFA01030759 | LIPID MAPS |
| Registry Numbers | Sources |
|---|---|
| Reaxys:1714433 | Reaxys |
| CAS:10417-94-4 | KEGG COMPOUND |
| CAS:10417-94-4 | ChemIDplus |
| Citations |
|---|